NATCOPHARM.NS vs. HCLTECH.NS

Last updated Jun 5, 2026

NATCOPHARM.NS (Natco Pharma Limited) and HCLTECH.NS (HCL Technologies Limited) are both stocks. NATCOPHARM.NS operates in Drug Manufacturers - Specialty & Generic (Healthcare), while HCLTECH.NS operates in Information Technology Services (Technology). Over the past 10 years, NATCOPHARM.NS returned 6.58%/yr vs 15.69%/yr for HCLTECH.NS. At a 0.16 correlation, their price movements are largely independent.

Performance

NATCOPHARM.NS vs. HCLTECH.NS - Performance Comparison

The chart below illustrates the hypothetical performance of a ₹10,000 investment in Natco Pharma Limited (NATCOPHARM.NS) and HCL Technologies Limited (HCLTECH.NS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NATCOPHARM.NS achieves a 1.91% return, which is significantly higher than HCLTECH.NS's -25.97% return. Over the past 10 years, NATCOPHARM.NS has underperformed HCLTECH.NS with an annualized return of 6.58%, while HCLTECH.NS has yielded a comparatively higher 15.69% annualized return.

NATCOPHARM.NS

• 1D: -1.69%
• 1M: -18.34%
• YTD: 1.91%
• 6M: -3.05%
• 1Y: 7.58%
• 3Y*: 14.17%
• 5Y*: -1.76%
• 10Y*: 6.58%

HCLTECH.NS

• 1D: -0.78%
• 1M: -2.67%
• YTD: -25.97%
• 6M: -27.56%
• 1Y: -25.04%
• 3Y*: 4.95%
• 5Y*: 8.88%
• 10Y*: 15.69%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NATCOPHARM.NS vs. HCLTECH.NS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NATCOPHARM.NS Natco Pharma Limited	1.91%	-34.53%	71.72%	46.21%	-37.35%	-5.57%	63.99%	-11.63%	-28.51%	67.49%
HCLTECH.NS HCL Technologies Limited	-25.97%	-12.63%	35.81%	47.94%	-17.71%	44.47%	68.64%	18.90%	8.50%	10.66%

Correlation

The correlation between NATCOPHARM.NS and HCLTECH.NS is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.18
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (10Y) Calculated over the trailing 10-year period	0.12
Correlation (All Time) Calculated using the full available price history since Jan 12, 2000	0.16

Return for Risk

NATCOPHARM.NS vs. HCLTECH.NS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NATCOPHARM.NS

NATCOPHARM.NS Risk / Return Rank: 46
NATCOPHARM.NS Sharpe Ratio Rank: 49
NATCOPHARM.NS Sortino Ratio Rank: 43
NATCOPHARM.NS Omega Ratio Rank: 43
NATCOPHARM.NS Calmar Ratio Rank: 49
NATCOPHARM.NS Martin Ratio Rank: 48

HCLTECH.NS

HCLTECH.NS Risk / Return Rank: 7
HCLTECH.NS Sharpe Ratio Rank: 5
HCLTECH.NS Sortino Ratio Rank: 8
HCLTECH.NS Omega Ratio Rank: 8
HCLTECH.NS Calmar Ratio Rank: 13
HCLTECH.NS Martin Ratio Rank: 4

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NATCOPHARM.NS vs. HCLTECH.NS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Natco Pharma Limited (NATCOPHARM.NS) and HCL Technologies Limited (HCLTECH.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NATCOPHARM.NS	HCLTECH.NS	Difference
Sharpe ratio: Return per unit of total volatility	0.20	-1.01	+1.21
Sortino ratio: Return per unit of downside risk	0.55	-1.29	+1.84
Omega ratio: Gain probability vs. loss probability	1.07	0.83	+0.24
Calmar ratio: Return relative to maximum drawdown	0.32	-0.76	+1.08
Martin ratio: Return relative to average drawdown	0.57	-1.63	+2.19
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NATCOPHARM.NS vs. HCLTECH.NS - Sharpe Ratio Comparison

The current NATCOPHARM.NS Sharpe Ratio is 0.20, which is higher than the HCLTECH.NS Sharpe Ratio of -1.01. The chart below compares the historical Sharpe Ratios of NATCOPHARM.NS and HCLTECH.NS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NATCOPHARM.NS	HCLTECH.NS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.20	-1.01	+1.21
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.05	0.37	-0.43
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.20	0.62	-0.42
Sharpe Ratio (All Time) Calculated using the full available price history	0.28	0.25	+0.03

Drawdowns

NATCOPHARM.NS vs. HCLTECH.NS - Drawdown Comparison

The maximum NATCOPHARM.NS drawdown since its inception was -89.98%, roughly equal to the maximum HCLTECH.NS drawdown of -92.20%. Use the drawdown chart below to compare losses from any high point for NATCOPHARM.NS and HCLTECH.NS.

Drawdown Indicators

	NATCOPHARM.NS	HCLTECH.NS	Difference
Max Drawdown Largest peak-to-trough decline	-89.98%	-92.20%	+2.22%
Max Drawdown (1Y) Largest decline over 1 year	-23.82%	-33.51%	+9.69%
Max Drawdown (3Y) Largest decline over 3 years	-53.00%	-40.03%	-12.97%
Max Drawdown (5Y) Largest decline over 5 years	-54.29%	-40.03%	-14.26%
Max Drawdown (10Y) Largest decline over 10 years	-55.44%	-40.03%	-15.41%
Current Drawdown Current decline from peak	-41.82%	-37.66%	-4.16%
Average Drawdown Average peak-to-trough decline	-35.81%	-32.84%	-2.97%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.36%	15.51%	-2.15%

Volatility

NATCOPHARM.NS vs. HCLTECH.NS - Volatility Comparison

Natco Pharma Limited (NATCOPHARM.NS) has a higher volatility of 18.16% compared to HCL Technologies Limited (HCLTECH.NS) at 9.51%. This indicates that NATCOPHARM.NS's price experiences larger fluctuations and is considered to be riskier than HCLTECH.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NATCOPHARM.NS	HCLTECH.NS	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.16%	9.51%	+8.65%
Volatility (6M) Calculated over the trailing 6-month period	29.61%	21.26%	+8.35%
Volatility (1Y) Calculated over the trailing 1-year period	38.00%	25.17%	+12.83%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	34.09%	24.19%	+9.90%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	34.21%	25.90%	+8.31%

Dividends

NATCOPHARM.NS vs. HCLTECH.NS - Dividend Comparison

NATCOPHARM.NS's dividend yield for the trailing twelve months is around 0.54%, less than HCLTECH.NS's 5.14% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HCLTECH.NS HCL Technologies Limited	5.14%	3.70%	2.81%	3.41%	4.63%	2.73%	1.06%	0.70%	0.83%	1.79%	2.91%	2.10%
NATCOPHARM.NS Natco Pharma Limited	0.54%	0.55%	0.41%	1.17%	1.11%	0.39%	0.91%	1.18%	1.25%	0.75%	0.35%	0.17%

Financials

Frequently Asked Questions

Can I hold both NATCOPHARM.NS and HCLTECH.NS in my portfolio?

NATCOPHARM.NS and HCLTECH.NS have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.